2021
DOI: 10.1101/2021.11.10.21265651
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK

Abstract: Background and aimsTo determine the impact of the COVID-19 pandemic on the population with chronic Hepatitis B virus (HBV) infection under hospital follow-up in the UK, we quantified the coverage and frequency of measurements of biomarkers used for routine surveillance (ALT and HBV viral load).MethodsWe used anonymised electronic health record data from the National Institute for Health Research (NIHR) Health Informatics Collaborative (HIC) pipeline representing five UK NHS Trusts.ResultsWe report significant … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…However, treatment data are most comprehensively captured in secondary/tertiary care records where HBV prescribing is based (60). In the NIHR Health Informatics Collaborative (HIC) secondary care EHR database, 16% of CHB patients were receiving antiviral treatment (61). Clinical guidelines recommend criteria for treatment, but it is not possible for us to determine the extent to which the 88% of patients with no treatment recorded are treatment ineligible, or are receiving treatment in a secondary/tertiary care setting that is not captured in QResearch data.…”
Section: Caveats Of Primary Care Ehr Analysis -Missing Datamentioning
confidence: 99%
“…However, treatment data are most comprehensively captured in secondary/tertiary care records where HBV prescribing is based (60). In the NIHR Health Informatics Collaborative (HIC) secondary care EHR database, 16% of CHB patients were receiving antiviral treatment (61). Clinical guidelines recommend criteria for treatment, but it is not possible for us to determine the extent to which the 88% of patients with no treatment recorded are treatment ineligible, or are receiving treatment in a secondary/tertiary care setting that is not captured in QResearch data.…”
Section: Caveats Of Primary Care Ehr Analysis -Missing Datamentioning
confidence: 99%